Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06112743
PHASE4

A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the mavacamten impact on myocardial structure with cardiac magnetic resonance imaging (CMR) in adult participants with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) \[New York Heart Association (NYHA) Functional Class II or III\].

Official title: MEMENTO - A Phase 4, Single-arm, Open-label Clinical Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy to Assess the Impact on Myocardial Structure With Cardiac Magnetic Resonance Imaging (CMR)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

63

Start Date

2024-01-24

Completion Date

2026-07-09

Last Updated

2025-09-22

Healthy Volunteers

No

Interventions

DRUG

Mavacamten

Specified dose on specified days

Locations (23)

Local Institution - 0087

West Hollywood, California, United States

Local Institution - 0003

Atlanta, Georgia, United States

Local Institution - 0093

Boston, Massachusetts, United States

Local Institution - 0090

Cleveland, Ohio, United States

Local Institution - 0086

Pittsburgh, Pennsylvania, United States

Local Institution - 0017

Houston, Texas, United States

Local Institution - 0035

Murray, Utah, United States

Local Institution - 0076

Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Local Institution - 0075

Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina

Local Institution - 0079

Pilar, Buenos Aires, Argentina

Local Institution - 0077

Córdoba, Córdoba Province, Argentina

Local Institution - 0074

Rosario, Santa Fe Province, Argentina

Local Institution - 0080

Buenos Aires, Argentina

Local Institution - 0015

Camperdown, New South Wales, Australia

Local Institution - 0085

Chermside, Queensland, Australia

Local Institution - 0005

Melbourne, Victoria, Australia

Local Institution - 0001

Montreal, Quebec, Canada

Local Institution - 0068

Québec, Quebec, Canada

Local Institution - 0058

Lucerne, Luzern (de), Switzerland

Local Institution - 0029

Lugano, Ticino (it), Switzerland

Local Institution - 0061

Geneva, Switzerland

Local Institution - 0024

Zürich (de), Switzerland

Local Institution - 0025

Leeds, Yorkshire, United Kingdom